Bailey John E. (jack) Jr. - Net Worth and Insider Trading
Bailey John E. (jack) Jr. Net Worth
The estimated net worth of Bailey John E. (jack) Jr. is at least $4 Million dollars as of 2024-11-05. Bailey John E. (jack) Jr. is the President and CEO of G1 Therapeutics Inc and owns about 549,674 shares of G1 Therapeutics Inc (GTHX) stock worth over $4 Million. Details can be seen in Bailey John E. (jack) Jr.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bailey John E. (jack) Jr. has not made any transactions after 2024-07-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bailey John E. (jack) Jr.
Bailey John E. (jack) Jr. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bailey John E. (jack) Jr. owns 1 companies in total, including G1 Therapeutics Inc (GTHX) .
Click here to see the complete history of Bailey John E. (jack) Jr.’s form 4 insider trades.
Insider Ownership Summary of Bailey John E. (jack) Jr.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GTHX | G1 Therapeutics Inc | 2024-07-05 | director & President and CEO |
Bailey John E. (jack) Jr. Latest Holdings Summary
Bailey John E. (jack) Jr. currently owns a total of 1 stock. Bailey John E. (jack) Jr. owns 549,674 shares of G1 Therapeutics Inc (GTHX) as of July 5, 2024, with a value of $4 Million.
Latest Holdings of Bailey John E. (jack) Jr.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GTHX | G1 Therapeutics Inc | 2024-07-05 | 549,674 | 7.15 | 3,930,169 |
Holding Weightings of Bailey John E. (jack) Jr.
Bailey John E. (jack) Jr. Form 4 Trading Tracker
According to the SEC Form 4 filings, Bailey John E. (jack) Jr. has made a total of 8 transactions in G1 Therapeutics Inc (GTHX) over the past 5 years, including 1 buys and 7 sells. The most-recent trade in G1 Therapeutics Inc is the sale of 7,662 shares on July 5, 2024, which brought Bailey John E. (jack) Jr. around $19,232.
Insider Trading History of Bailey John E. (jack) Jr.
- 1
Bailey John E. (jack) Jr. Trading Performance
GuruFocus tracks the stock performance after each of Bailey John E. (jack) Jr.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bailey John E. (jack) Jr. is 158.86%. GuruFocus also compares Bailey John E. (jack) Jr.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Bailey John E. (jack) Jr. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bailey John E. (jack) Jr.'s insider trading performs compared to the benchmark.
Performance of Bailey John E. (jack) Jr.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 50.75 | | | | | |
| Relative Return to S&P 500(%) | 48.21 | | | | | |
Bailey John E. (jack) Jr. Ownership Network
Ownership Network List of Bailey John E. (jack) Jr.
Ownership Network Relation of Bailey John E. (jack) Jr.
Bailey John E. (jack) Jr. Owned Company Details
What does G1 Therapeutics Inc do?
Who are the key executives at G1 Therapeutics Inc?
Bailey John E. (jack) Jr. is the director & President and CEO of G1 Therapeutics Inc. Other key executives at G1 Therapeutics Inc include Chief Financial Officer John V. Umstead , Chief Commercial Officer Andrew Perry , and Chief Business Officer Mark Avagliano .
G1 Therapeutics Inc (GTHX) Insider Trades Summary
Over the past 18 months, Bailey John E. (jack) Jr. made 5 insider transaction in G1 Therapeutics Inc (GTHX) with a net sale of 92,308. Other recent insider transactions involving G1 Therapeutics Inc (GTHX) include a net sale of 78,166 shares made by Rajesh Malik , a net sale of 15,968 shares made by John V. Umstead , and a net sale of 15,727 shares made by Terry L Murdock .
In summary, during the past 3 months, insiders sold 0 shares of G1 Therapeutics Inc (GTHX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 295,121 shares of G1 Therapeutics Inc (GTHX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 295,121 shares.
G1 Therapeutics Inc (GTHX)'s detailed insider trading history can be found in Insider Trading Tracker table.
G1 Therapeutics Inc Insider Transactions
Bailey John E. (jack) Jr. Mailing Address
Above is the net worth, insider trading, and ownership report for Bailey John E. (jack) Jr.. You might contact Bailey John E. (jack) Jr. via mailing address: C/o G1 Therapeutics, Inc., 700 Park Offices Drive, Suite 200, Research Triangle Park Nc 27709.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
